BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Adipose tissue
,
Holistic medicine
,
Bleomycin
,
rs4950928
,
PPARA
,
Pseudomonas infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
factor D
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Factor D.
Plasma factor D is cross-sectionally associated with low-grade inflammation, endothelial dysfunction…
Quantification of the zymogenicity and the substrate-induced activity enhancement of complement fact…
The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
Novel Insights into Factor D Inhibition.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Fa…
Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]
The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome
Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy
Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ